Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Murphy

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2007
Antiretroviral therapy for advanced naïve HIV-infected patients: current status and comparison of two different management strategiesRobert L Murphy
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2003
Reviving protease inhibitors: new data and more optionsRobert L Murphy
The AIDS Reader|December 8, 2009
Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease managementRobert L Murphy
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
Defining the toxicity profile of nevirapine and other antiretroviral drugsRobert L Murphy
JAMA Network Open|October 8, 2025
Global Crises and Worsening Health Outcomes-Unmasking the Pandemic GhostJonah Musa, Robert L Murphy
AIDS (London, England)|July 23, 2003
Clinical and biological insights in HIV-associated cardiovascular disease in the era of highly active antiretroviral therapyRobert L Murphy, Giuseppe Barbaro
Current Opinion in HIV and AIDS|January 6, 2010
Management of antiretroviral failure and resistance in developing countriesClaudia Hawkins, Robert L Murphy
Cytometry. Part B, Clinical Cytometry|December 7, 2007
Clinical applications and availability of CD4+ T cell count testing in sub-Saharan AfricaBabafemi O Taiwo, Robert L Murphy
Drugs|August 25, 2010
Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and resultsBabafemi Taiwo, Robert L Murphy, Christine Katlama
AIDS (London, England)|March 31, 2017
Individualized antiretroviral therapeutic approaches: less can be moreChristine Katlama, Jade Ghosn, Robert L Murphy
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2007
Antiretroviral therapy for advanced naïve HIV-infected patients: current status and comparison of two different management strategiesRobert L Murphy
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2003
Reviving protease inhibitors: new data and more optionsRobert L Murphy
The AIDS Reader|December 8, 2009
Utilizing a new class of antiretrovirals: role of fusion inhibitors in HIV disease managementRobert L Murphy
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2003
Defining the toxicity profile of nevirapine and other antiretroviral drugsRobert L Murphy
JAMA Network Open|October 8, 2025
Global Crises and Worsening Health Outcomes-Unmasking the Pandemic GhostJonah Musa, Robert L Murphy
AIDS (London, England)|July 23, 2003
Clinical and biological insights in HIV-associated cardiovascular disease in the era of highly active antiretroviral therapyRobert L Murphy, Giuseppe Barbaro
Current Opinion in HIV and AIDS|January 6, 2010
Management of antiretroviral failure and resistance in developing countriesClaudia Hawkins, Robert L Murphy
Cytometry. Part B, Clinical Cytometry|December 7, 2007
Clinical applications and availability of CD4+ T cell count testing in sub-Saharan AfricaBabafemi O Taiwo, Robert L Murphy
Drugs|August 25, 2010
Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and resultsBabafemi Taiwo, Robert L Murphy, Christine Katlama
AIDS (London, England)|March 31, 2017
Individualized antiretroviral therapeutic approaches: less can be moreChristine Katlama, Jade Ghosn, Robert L Murphy
Pageof 18